Delcath Systems (NSDQ:DCTH) has raised $2 million after selling 2,360 shares of Series B preferred stock at $1,000 per share to unnamed institutional investors, according to a regulatory filing.
The company wrote that it plans to use the proceeds for general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.